Millfield Group PLC
09 January 2006
Millfield Group Plc ("Millfield" or the "Company")
Statement re. Press Comment
Paul Tebbutt, CEO, Millfield, comments "The board of Millfield notes recent
press comment concerning its capital adequacy requirements. As reported in the
Interim Results on 1 December 2005, the group's regulated companies reported a
surplus on all regulatory capital adequacy requirements imposed by the Financial
Services Authority until 30 September 2005, but expected a shortfall in the 4Q
2005.
The directors reported a shortfall of capital adequacy test 2 to the FSA of
£0.8m at the end of November and expects the shortfall to be £1.5m when the
December FSA return is finalised. The group has large surpluses on FSA capital
adequacy tests 1 and 1a. Group cash balances at end November amounted to £8.1m.
The board is implementing further measures to strengthen the group balance sheet
and is confident that it will eliminate the shortfall on test 2 in due course".
For further information:
Paul Tebbutt, Millfield - 07958 992812
Mark Llewellyn-Slade, Llewellyn-Slade PR - 07770 380647
9 January 2006
This information is provided by RNS
The company news service from the London Stock Exchange SPCUKVURNWRARAR
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.